Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases
暂无分享,去创建一个
M. Süße | T. Witte | M. Hannich | S. Gingele | T. Skripuletz | M. Grothe | F. F. Konen | Philipp Schwenkenbecher | K. Jendretzky | K. Sühs
[1] B. Weinshenker,et al. CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis. , 2021, Mayo Clinic proceedings.
[2] H. Tumani,et al. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis , 2021, Cells.
[3] B. Mroczko,et al. Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment , 2021, Journal of clinical medicine.
[4] T. Zrzavy,et al. Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study , 2021, Frontiers in Immunology.
[5] A. Petersmann,et al. Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern , 2021, Cells.
[6] M. Süße,et al. The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid , 2021, Journal of central nervous system disease.
[7] M. Stangel,et al. Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases , 2020, Diagnostics.
[8] U. Dianzani,et al. Intrathecal kappa free light chains as markers for multiple sclerosis , 2020, Scientific Reports.
[9] M. Nauck,et al. Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[10] A. Petersmann,et al. Free light chain kappa and the polyspecific immune response in MS and CIS – Application of the hyperbolic reference range for most reliable data interpretation , 2020, Journal of Neuroimmunology.
[11] M. Nauck,et al. Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[12] H. Tumani,et al. The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation , 2020, Cells.
[13] M. Ciaccio,et al. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis. , 2020, Laboratory medicine.
[14] P. Cavalla,et al. Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders , 2019, Journal of Neuroimmunology.
[15] T. Witte,et al. Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis? , 2019, Diagnostics.
[16] H. Reiber,et al. Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[17] J. Lewerenz,et al. Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis , 2019, Front. Neurol..
[18] A. Henningsson,et al. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis – a pilot study , 2019, Clinical chemistry and laboratory medicine.
[19] A. Ludolph,et al. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort , 2019, Front. Immunol..
[20] U. Rot,et al. Intrathecal immunoglobulin synthesis: The potential value of an adjunct test. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[21] A. Petersmann,et al. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands , 2018, European journal of neurology.
[22] F. Deisenhammer,et al. Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis , 2018, Clinical chemistry and laboratory medicine.
[23] D. Murray,et al. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes , 2018, Clinical chemistry and laboratory medicine.
[24] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[25] A. Enguix,et al. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm , 2017, Clinical chemistry and laboratory medicine.
[26] G. Bellomo,et al. Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs. , 2017, Clinical laboratory.
[27] P. Hradílek,et al. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting , 2016, PloS one.
[28] H. Tumani,et al. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study , 2016, Multiple sclerosis.
[29] G. Giovannoni,et al. The effects of intrathecal rituximab on biomarkers in multiple sclerosis. , 2016, Multiple sclerosis and related disorders.
[30] A. Petzold. Intrathecal oligoclonal IgG synthesis in multiple sclerosis , 2013, Journal of Neuroimmunology.
[31] F. Fazekas,et al. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis , 2013, Multiple sclerosis.
[32] E. Meinl,et al. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis , 2013, Nature Reviews Neurology.
[33] K. Trinkaus,et al. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. , 2010, Archives of neurology.
[34] P. Dayan,et al. Effect of Antibiotic Pretreatment on Cerebrospinal Fluid Profiles of Children With Bacterial Meningitis , 2008, Pediatrics.
[35] T. Brücke,et al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis , 2008, Journal of Neurology.
[36] Michael J. Ramsbottom,et al. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients , 2006, Journal of Neuroimmunology.
[37] Hansotto Reiber,et al. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs , 2001, Journal of the Neurological Sciences.
[38] G. Bernardi,et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[39] I. Donaldson,et al. Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. , 1990, Australian and New Zealand journal of medicine.
[40] Deborah S. Smith,et al. Cerebrospinal fluid changes after 48 hours of effective therapy for Hemophilus influenzae type B meningitis. , 1990, American journal of clinical pathology.
[41] E. Thompson,et al. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[42] B. Brooks,et al. Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases , 1983, Annals of neurology.
[43] H. Reiber. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. , 2003, Restorative neurology and neuroscience.